Today’s top gainers include the company Gilead Sciences Inc. (NASDAQ:GILD) which is in the industry Biotechnology, gaining 1.62% today. In the last week its performance is -2.77%, and -6.20% for the past quarter. Currently, Gilead Sciences Inc., GILD has a target price of 103.5, so today’s gain of 1.62% is a significant step towards its target price. The GAP today is therefore 0.26%.
Gilead Sciences Inc. (NASDAQ:GILD), has a market cap of 105625.2, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 80.50%.
At the current price of 79.12, it has a dividend yield of 2.38%, and its target price is 103.5. This is with a profit margin of 50.50%, and total debt/equity of 1.42. Gilead Sciences Inc. (NASDAQ:GILD) has a P/E of 6.97, as well as a forward P/E of 6.85.
With a current EPS of 11.35, and a forecasted EPS growth for next year at -1.79%,Gilead Sciences Inc. (NASDAQ:GILD) has had a EPS growth for the past five years at 48.30%. For the next five years EPS growth is projected to be -0.21%.
Performance for the year is -17.80%. Since its IPO date on 1/22/1992, the total performance to date is -20.51%.
Volume today for Gilead Sciences Inc. (NASDAQ:GILD), is 10995800, while its average volume is 10503.61. Whilst the total gain today was 1.62%, it did have a day high of -10.41%.
Volatility for this week has been at 1.69%, and 1.59% for the month. The 52-week low for Gilead Sciences Inc., GILD has been 3.82%, while the 52-week-high has reached -27.30%.
Looking at its return of investments, which is 45.90%, and its return on assets is 32.70%. Gilead Sciences Inc. (NASDAQ:GILD) has an operating margin of 63.00%. With a sales growth of -5.70% quarter over quarter. Bearing in mind that Gilead Sciences Inc., GILD is in the sector Healthcare, its long-term debt/equity is 1.38, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of Gilead Sciences Inc.? Well its PEG is *TBA, and the P/S is 3.26, along with a P/B of 6.8. Meanwhile it has a p/cash of 12.07.